Longboard Pharmaceuticals Stock Price Prediction

LBPH Stock  USD 59.80  0.03  0.05%   
The RSI of Longboard Pharmaceuticals' share price is above 70 as of 22nd of November 2024. This indicates that the stock is becoming overbought or overvalued. The idea behind Relative Strength Index (RSI) is that it helps to track how fast people are buying or selling Longboard, making its price go up or down.

Oversold Vs Overbought

79

 
Oversold
 
Overbought
The successful prediction of Longboard Pharmaceuticals' future price could yield a significant profit. We analyze noise-free headlines and recent hype associated with Longboard Pharmaceuticals, which may create opportunities for some arbitrage if properly timed. Below are the key fundamental drivers impacting Longboard Pharmaceuticals' stock price prediction:
EPS Estimate Next Quarter
(0.62)
EPS Estimate Current Year
(2.27)
EPS Estimate Next Year
(2.74)
Wall Street Target Price
64.6667
EPS Estimate Current Quarter
(0.58)
Using Longboard Pharmaceuticals hype-based prediction, you can estimate the value of Longboard Pharmaceuticals from the perspective of Longboard Pharmaceuticals response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Longboard Pharmaceuticals to buy its stock at a price that has no basis in reality. In that case, they are not buying Longboard because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.

Longboard Pharmaceuticals after-hype prediction price

    
  USD 59.77  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
  
Check out Longboard Pharmaceuticals Basic Forecasting Models to cross-verify your projections.
For more detail on how to invest in Longboard Stock please use our How to Invest in Longboard Pharmaceuticals guide.
Intrinsic
Valuation
LowRealHigh
40.7548.4165.75
Details
Naive
Forecast
LowNextHigh
56.6464.3071.97
Details
7 Analysts
Consensus
LowTargetHigh
15.8617.4319.35
Details
Earnings
Estimates (0)
LowProjected EPSHigh
-0.57-0.57-0.57
Details

Longboard Pharmaceuticals After-Hype Price Prediction Density Analysis

As far as predicting the price of Longboard Pharmaceuticals at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Longboard Pharmaceuticals or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Longboard Pharmaceuticals, with the unreliable approximations that try to describe financial returns.
   Next price density   
       Expected price to next headline  

Longboard Pharmaceuticals Estimiated After-Hype Price Volatility

In the context of predicting Longboard Pharmaceuticals' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Longboard Pharmaceuticals' historical news coverage. Longboard Pharmaceuticals' after-hype downside and upside margins for the prediction period are 52.11 and 67.43, respectively. We have considered Longboard Pharmaceuticals' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
59.80
59.77
After-hype Price
67.43
Upside
Longboard Pharmaceuticals is not too volatile at this time. Analysis and calculation of next after-hype price of Longboard Pharmaceuticals is based on 3 months time horizon.

Longboard Pharmaceuticals Stock Price Prediction Analysis

Have you ever been surprised when a price of a Company such as Longboard Pharmaceuticals is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Longboard Pharmaceuticals backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Longboard Pharmaceuticals, there might be something going there, and it might present an excellent short sale opportunity.
Expected ReturnPeriod VolatilityHype ElasticityRelated ElasticityNews DensityRelated DensityExpected Hype
  0.97 
7.60
  0.07 
  0.15 
9 Events / Month
14 Events / Month
In about 9 days
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility
59.80
59.77
0.00 
10,857  
Notes

Longboard Pharmaceuticals Hype Timeline

Longboard Pharmaceuticals is now traded for 59.80. The entity has historical hype elasticity of -0.07, and average elasticity to hype of competition of -0.15. Longboard is projected not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is over 100%. The immediate return on the next news is projected to be very small, whereas the daily expected return is now at 0.97%. %. The volatility of related hype on Longboard Pharmaceuticals is about 5082.8%, with the expected price after the next announcement by competition of 59.65. About 99.0% of the company shares are owned by institutional investors. The company recorded a loss per share of 2.25. Longboard Pharmaceuticals had not issued any dividends in recent years. Given the investment horizon of 90 days the next projected press release will be in about 9 days.
Check out Longboard Pharmaceuticals Basic Forecasting Models to cross-verify your projections.
For more detail on how to invest in Longboard Stock please use our How to Invest in Longboard Pharmaceuticals guide.

Longboard Pharmaceuticals Related Hype Analysis

Having access to credible news sources related to Longboard Pharmaceuticals' direct competition is more important than ever and may enhance your ability to predict Longboard Pharmaceuticals' future price movements. Getting to know how Longboard Pharmaceuticals' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Longboard Pharmaceuticals may potentially react to the hype associated with one of its peers.
Hype
Elasticity
News
Density
Semi
Deviation
Information
Ratio
Potential
Upside
Value
At Risk
Maximum
Drawdown
MOLNMolecular Partners AG(0.10)5 per month 5.15 (0.01) 9.61 (8.53) 52.92 
MNOVMediciNova 0.16 9 per month 4.13  0.11  14.50 (8.50) 61.30 
ANEBAnebulo Pharmaceuticals(0.07)6 per month 0.00 (0.02) 8.85 (11.48) 76.00 
CSBRChampions Oncology(0.24)6 per month 3.87 (0.02) 6.23 (6.96) 22.49 
CYTCyteir Therapeutics 0.09 2 per month 2.57  0.08  10.00 (5.26) 36.14 
HOWLWerewolf Therapeutics(0.02)6 per month 0.00 (0.02) 9.21 (8.75) 49.02 
EWTXEdgewise Therapeutics(0.04)9 per month 3.05  0.10  6.65 (5.51) 61.02 
DBTXDecibel Therapeutics 0.01 1 per month 4.12  0.06  7.85 (7.45) 26.09 
CELCCelcuity LLC(0.05)9 per month 0.00 (0.18) 4.02 (5.73) 16.97 
CCCCC4 Therapeutics(0.35)9 per month 0.00 (0.12) 9.57 (7.98) 23.66 
ASMBAssembly Biosciences(0.72)7 per month 4.40 (0) 8.49 (5.34) 24.80 
NXTCNextCure 0.01 5 per month 0.00 (0.12) 5.22 (5.52) 21.68 
NUVBNuvation Bio 0.21 8 per month 4.53 (0.01) 9.48 (8.36) 21.30 
GRPHGraphite Bio(0.03)1 per month 0.00 (0.07) 4.79 (4.73) 14.40 
TILInstil Bio(1.77)9 per month 6.84  0.12  20.63 (10.89) 105.83 
SNSESensei Biotherapeutics 0.05 4 per month 7.39  0.01  9.80 (13.21) 110.76 
MACKMerrimack Pharmaceuticals 0.00 0 per month 0.00 (0.14) 1.89 (1.74) 7.02 
GLUEMonte Rosa Therapeutics(0.25)7 per month 4.44  0.06  10.11 (8.29) 102.66 
DSGNDesign Therapeutics 0.06 4 per month 5.44  0.03  9.61 (8.21) 35.31 
IKNAIkena Oncology(0.05)3 per month 1.38 (0.06) 1.81 (1.74) 13.50 
STOKStoke Therapeutics(0.04)7 per month 0.00 (0.12) 4.68 (7.09) 21.35 

Longboard Pharmaceuticals Additional Predictive Modules

Most predictive techniques to examine Longboard price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Longboard using various technical indicators. When you analyze Longboard charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About Longboard Pharmaceuticals Predictive Indicators

The successful prediction of Longboard Pharmaceuticals stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Longboard Pharmaceuticals, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Longboard Pharmaceuticals based on analysis of Longboard Pharmaceuticals hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Longboard Pharmaceuticals's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Longboard Pharmaceuticals's related companies.
 2021 2022 2023 2024 (projected)
Current Ratio19.917.975.144.88
Net Debt To EBITDA2.360.220.240.23

Story Coverage note for Longboard Pharmaceuticals

The number of cover stories for Longboard Pharmaceuticals depends on current market conditions and Longboard Pharmaceuticals' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Longboard Pharmaceuticals is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Longboard Pharmaceuticals' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.

Longboard Pharmaceuticals Short Properties

Longboard Pharmaceuticals' future price predictability will typically decrease when Longboard Pharmaceuticals' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Longboard Pharmaceuticals often depends not only on the future outlook of the potential Longboard Pharmaceuticals' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Longboard Pharmaceuticals' indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding22.7 M
Cash And Short Term Investments48.5 M

Complementary Tools for Longboard Stock analysis

When running Longboard Pharmaceuticals' price analysis, check to measure Longboard Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Longboard Pharmaceuticals is operating at the current time. Most of Longboard Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Longboard Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Longboard Pharmaceuticals' price. Additionally, you may evaluate how the addition of Longboard Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Equity Valuation
Check real value of public entities based on technical and fundamental data
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Stocks Directory
Find actively traded stocks across global markets